Expect Equity LLC Buys Shares of 76,261 Option Care Health, Inc. (NASDAQ:OPCH)

Expect Equity LLC acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 76,261 shares of the company’s stock, valued at approximately $1,769,000.

Other large investors have also recently made changes to their positions in the company. D. E. Shaw & Co. Inc. bought a new position in shares of Option Care Health in the fourth quarter worth approximately $4,657,000. Deutsche Bank AG boosted its holdings in Option Care Health by 8.5% during the 4th quarter. Deutsche Bank AG now owns 637,305 shares of the company’s stock valued at $14,785,000 after acquiring an additional 50,149 shares during the period. Corton Capital Inc. bought a new position in shares of Option Care Health in the fourth quarter worth approximately $251,000. Brevan Howard Capital Management LP increased its position in shares of Option Care Health by 218.4% in the fourth quarter. Brevan Howard Capital Management LP now owns 26,338 shares of the company’s stock valued at $611,000 after acquiring an additional 18,067 shares during the period. Finally, Balyasny Asset Management L.P. increased its holdings in Option Care Health by 338.0% during the 4th quarter. Balyasny Asset Management L.P. now owns 168,082 shares of the company’s stock valued at $3,900,000 after purchasing an additional 129,708 shares during the period. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Shares of OPCH opened at $31.70 on Friday. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market cap of $5.19 billion, a price-to-earnings ratio of 26.64, a PEG ratio of 2.30 and a beta of 0.76. The business has a 50-day simple moving average of $33.29 and a two-hundred day simple moving average of $28.89. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm’s revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.26 EPS. On average, analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. JMP Securities reaffirmed a “market outperform” rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Barrington Research reiterated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.